Connor, Clark & Lunn Investment Management Ltd.

Position in INGN — Inogen Inc

CIK 1596800 VANCOUVER, A1

Position in INGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$268,223

-$98,522 QoQ

Shares Held

41,585

-29.9% QoQ

Ownership

0.157%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 128 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. INGN ranks #22 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$268,223	41,585	-29.9%	Shares	Sole	2026-08-13
2026-03-31	$366,745	59,344	-54.3%	Shares	Sole	2026-05-11
2025-12-31	$872,686	129,864	-30.9%	Shares	Sole	2026-02-10
2025-09-30	$1,536,319	188,044	-31.7%	Shares	Sole	2025-11-13
2025-06-30	$1,935,830	275,367	-2.9%	Shares	Sole	2025-08-07
2025-03-31	$2,021,105	283,465	+13.9%	Shares	Sole	2025-05-12
2024-12-31	$2,281,697	248,822	+42.5%	Shares	Sole	2025-02-10
2024-09-30	$1,693,862	174,625	+312.5%	Shares	Sole	2024-11-08
2024-06-30	$344,207	42,338	+23.1%	Shares	Sole	2024-08-09
2024-03-31	$277,599	34,399	+71.7%	Shares	Sole	2024-05-09
2023-12-31	$109,970	20,031	-50.1%	Shares	Sole	2024-02-09
2023-06-30	$463,686	40,146	+442.5%	Shares	Sole	2023-08-10
2020-03-31	$382,284	7,400	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.